UCB9741

DRUG2 trials

Sponsors

UCB Biopharma SRL

Conditions

Atopic DermatitisHealthy Participants

Phase 1

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

CompletedNCT04643457

UCB Biopharma SRLAtopic Dermatitis

Start: 2020-11-27End: 2024-06-06Updated: 2025-09-30

A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanese Participants

CompletedNCT06315335

UCB Biopharma SRLHealthy Participants

Start: 2024-07-01End: 2025-01-01Updated: 2025-11-28